Invictus Pharmacy and Mullan Pharmaceutical Expand Patient Access to Ganirelix Acetate Injection

Invictus Pharmacy has partnered with Mullan Pharmaceutical to expand patient access to ganirelix acetate injection (250 mcg/0.5 ml), a medication used during in vitro fertilization (IVF) to help prevent premature ovulation during treatment cycles.

Under the agreement, Mullan will supply the medication to Invictus Pharmacy, which will fulfill valid prescriptions nationwide through its licensed digital and mail-order pharmacy platform — giving fertility patients across all 50 states faster, more transparent, and more affordable access to a medication where timing is critical.

Invictus Pharmacy founder and CEO Meyer Davidoff said the partnership reflects the company's broader goal of removing unnecessary barriers between patients and the medications they're prescribed.

Source: Sandra Levy, "Invictus Pharmacy, Mullan Pharmaceutical expand patient access to ganirelix acetate injection," Drug Store News, July 8, 2026. Read it at https://drugstorenews.com/invictus-pharmacy-mullan-pharmaceutical-expand-patient-access-ganirelix-acetate-injection